card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in Europe

Home / Insights / A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in Europe

In this presentation, IQVIA Laboratories and Illumina discuss key strategies for European oncology clinical trials and the benefits of a global laboratory network for genomic biomarker testing. You will learn the science behind comprehensive genomic profiling (CGP), its advantages and the emergence of key oncology biomarkers that are acting to disrupt the CDx testing landscape. Presenters uncover the role that Illumina and IQVIA Laboratories play in building a global laboratory network to support local testing for oncology precision medicine trials. In addition, they explore how this model accelerates timelines and removes common complications observed during biomarker translation and clinical trial testing. Lastly, you will gain insights on the roadmap for Q2 Solution’s Edinburgh laboratory and the full suite of cutting-edge genomic solutions they provide.

Presentation slides available for download. You may also Watch On Demand.

Speakers:

  • Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics, IQVIA Laboratories
  • Bert De Boer, Sr. Manager, Sales Specialists, Clinical Sales, EMEA, Illumina
  • Megan Townsend, Business Development Analyst, CDx Partnering, EMEA, Illumina